Clinical Study Aims to Evaluate Vitiligo Repigmentation System

AVITA Therapeutics Inc announces the initiation of a pivotal study assessing the use of the RECELL System to treat stable vitiligo with the enrollment of the first patient at Miami Dermatology and Laser Institute in Miami, FL, according to a media release.